Sanofi Pasteur enlists actor Chris O’Donnell in flu vaccine campaign
SWIFTWATER, Pa. — The vaccines division of French drug maker Sanofi has signed a deal with actor Chris O’Donnell to promote its flu vaccination products, the company said.
Sanofi Pasteur’s campaign includes an effort to build awareness of influenza and vaccine options, including the company’s Fluzone Intradermal vaccine, for adults through the age of 65 years. O’Donnell has appeared in such movies as "Fried Green Tomatoes" and "Kinsey," and more recently in such television shows as "NCIS: Los Angeles."
The Centers for Disease Control and Prevention recommends flu vaccinations for everyone ages 6 months and older. However, according to a recent GfK Roper telephone survey of 663 adults, while 67% of those through 64 years of age say their biggest fear is spreading the virus to loved ones, 61% say they are not vaccinated against it. According to health experts, infants and elderly people are considered particularly at risk of serious complications, including death, from influenza.
No comments found
FDA approves Lupin depression, anxiety drug
BALTIMORE — The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.
The Indian drug maker announced the approval of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, used for acute and maintenance treatment of major depressive disorder in adults and adolescents and for acute treatment of general anxiety disorder in adults.
The drug is a generic version of Forest Labs’ Lexapro, which had sales of about $2.7 billion during the 12-month period that ended in June 2012, according to IMS Health.
Food and Drug Administration an organization which worked from years to protect and promoting public health through various policies and reforms acts. So before passing or approves any drugs, medicine and diet pills FDA first give the clearance then afterwards these cases are approved. Escitalopram tablets in the 5-mg, 10-mg and 20-mg mostly known as anxiety drugs is now approved by FDA for public use. http://redifininghealth.blogspot.in
Pfizer, Chinese drug maker ink branded generics deal
HANGZHOU, China — Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.
Pfizer said it had partnered with Zhejiang Hisun Pharmaceuticals, based in the city of Hangzhou, south of Shanghai on China’s eastern coast. The partnership, called Hisun-Pfizer, will operate as a joint venture developing, manufacturing and commercializing branded generics, an umbrella term used to describe branded drugs with active pharmaceutical ingredients that have lost patent protection. Hisun-Pfizer has an aggregate investment of $295 million and a registered capital of $250 million, with Hisun owning a 51% share and Pfizer owning 49%, the companies said.
"Providing high-quality, accessible and affordable health care to people over a vast area and from broad socioeconomic levels has become a primary objective of Chinese healthcare reforms, which is aligned with Pfizer’s mission to provide high-equality and affordable medicines to our patients," Pfizer country manager for China Wu Xiaobing said. "The joint venture demonstrates Pfizer’s commitment to China’s ongoing healthcare reforms and is an important milestone for Pfizer’s efforts to broaden the reach of its world-class healthcare solutions in China."
No comments found